Cambridge Enterprise

Cambridge Enterprise is a corporate venture capital firm based in Cambridge, United Kingdom, established in 2006. The firm focuses on investing in high-impact, high-growth spin-outs and start-ups that emerge from the University of Cambridge. With a particular emphasis on the life sciences and medical technology sectors, Cambridge Enterprise aims to support innovative companies that have the potential to make significant advancements in their fields. By leveraging the university's research and expertise, the firm seeks to foster the development of transformative solutions that address pressing challenges in health and technology.

Christopher Gibbs

Investment Director, Physical Sciences

James Thomas

Investor Board representative (Consultant)

4 past transactions

TRIMTECH Therapeutics

Seed Round in 2025
TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD).

illumion

Seed Round in 2024
Illumion is a company focused on transforming energy storage using light. Illumion aims to revolutionize how energy is stored and transferred by utilizing light to enhance the efficiency and performance of energy storage systems.

52 North

Venture Round in 2024
52 North Health aims to improve healthcare with a medical device that uses artificial intelligence (AI) to determine the risk of neutropenic sepsis for patients undergoing chemotherapy.

AllFocal Optics

Seed Round in 2024
AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.